Just How Many Pharma's Lose As Insmed Wins in both NTM And CF
If you want to understand why these clowns come out of the woodwork as Insmed sees increasing successes with their trials just look at the current marketplace. Billions of dollars are at stake for a half dozen or more companies with inferior and largely ineffective products being used today. And, when you look at the other indications they feel they may be able to supply the market for, billions more. Big pharma is about to have tens of billions of high-value patented drugs expire. Now they have to deal with lower value but significant revenue producing drugs becoming obsolete compliments of Insmed and their pipeline. This is just starting to get interesting.
This brings up another question as to what exactly we have. Am I correct to assume our product is not a new drug but a new approach/application of existing products with a new delivery device in the eyes of the FDA ?